EDTA (disodium)

CAT: 0804-HY-W018746-01Size: 10 gDry Ice: NoHazardous: No
CAT#:0804-HY-W018746-01Size:10 g
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
EDTA disodium salt, also known as ethylenediaminetetraacetic acid disodium, belongs to the chelating agent category, which is formed by chelating a central metal ion with four carboxylate groups and two amine groups. This compound, with its ability to bind and chelate metal ions such as calcium, magnesium and iron, is commonly used in a variety of applications, including industrial, medical and research settings. It is used as a preservative in food and beverage, as a stabilizer in medicine, as a chelating agent in water treatment, and as a reagent in biochemical and biomedical research. In addition, EDTA disodium salt has been studied for potential research effects such as improving heavy metal poisoning and cardiovascular disease.
CAS Number
[139-33-3]
Product Name Alternative
Ethylenediaminetetraacetic acid (disodium)
UNSPSC
12352200
Hazard Statement
H302+H332, H318, H373
Target
Biochemical Assay Reagents
Type
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/edta-disodium.html
Purity
99.2
Solubility
H2O : 20 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(O)CN(CC(O)=O)CCN(CC(O[Na])=O)CC(O[Na])=O
Molecular Formula
C10H14N2Na2O8
Molecular Weight
336.21
Precautions
H302+H332, H318, H373
References & Citations
Environ Sci Technol. 2017 Dec 5;51(23):13938-13948.|Adv Sci (Weinh). 2022 Dec 12;e2204998.|bioRxiv. 2023 Sep 8.|Cell Immunol. 2023 Nov 2, 104781.|Colloids Surf B Biointerfaces. 2023 Dec 2, 113680.|Int J Biol Macromol. 2022.|Molecules. 2024 Jul 30;29(15):3590.|Nucleic Acids Res. 2024 Nov 30:gkae1112.|Biomed Pharmacother. 2019 Jan;109:2427-2433. |Molecules. 2021 Aug 24;26(17):5115.|Research Square Preprint. 2021 Oct.
Shipping Conditions
Room Temperature
Storage Conditions
Store at room temperature 3 years
Scientific Category
Biochemical Assay Reagents
Clinical Information
Phase 4
Citation 01
Environ Sci Technol. 2017 Dec 5;51 (23) :13938-13948.|Adv Sci (Weinh) . 2023 Feb;10 (4) :e2204998.|Adv Sci (Weinh) . 2024 Dec 25:e2411261.|Adv Sci (Weinh) . 2025 Feb 8:e2415229.|Ann Med. 2025 Dec;57 (1) :2548045.|bioRxiv. 2023 Sep 8.|BMC Med Genomics. 2025 Aug 9;18 (1) :128.|Bone Res. 2025 Mar 3;13 (1) :30.|Cell Immunol. 2024 Jan-Feb:395-396:104781.|Colloids Surf B Biointerfaces. 2024 Feb:234:113680.|EMBO Mol Med. 2025 Oct 15.|Food Qual Saf. 2025 Aug 4.|Int J Biol Macromol. 2023 Jan 15:225:1182-1192.|Int J Biol Macromol. 2025 May 7:144068.|Int J Biol Macromol. 2026 Jan;335 (Pt 2) :149182.|J Extracell Vesicles. 2025 Sep;14 (9) :e70162.|J Nanobiotechnology. 2025 Mar 6;23 (1) :175.|J Orthop Surg Res. 2025 Apr 22;20 (1) :403.|Molecules. 2024 Jul 30;29 (15) :3590.|Nat Immunol. 2025 Oct;26 (10) :1660-1672.|Neuron. 2025 Jul 29:S0896-6273 (25) 00509-4.|Nucleic Acids Res. 2024 Nov 30:gkae1112.

Popular Products